Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDER “De-Layering” Slated For Late 2003, Following OC Shuffling

This article was originally published in The Tan Sheet

Executive Summary

FDA's Center for Drug Evaluation & Research will be reorganized along with the rest of the agency's centers in mid- to late-2003
Advertisement

Related Content

HHS Public Affairs Centralization Plan May Ease FDA Appointment
HHS Public Affairs Centralization Plan May Ease FDA Appointment

Topics

Advertisement
UsernamePublicRestriction

Register

PS094719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel